Blockchain Registration Transaction Record

Nanox.AI Expands UK Reach and Local AI Inference with Intel

Nanox.AI signs UK reseller deal with Vertec Scientific for HealthOST and partners with Intel to enable local AI inference, advancing medical imaging analytics.

This news matters because it addresses a critical gap in diagnostic imaging: the vast number of undiagnosed conditions that are visible on routine CT scans but often overlooked. By enabling AI to identify vertebral fractures and other abnormalities, Nanox.AI can help clinicians intervene earlier, potentially preventing further complications and improving patient outcomes. The UK reseller agreement with Vertec Scientific means that this technology will become more accessible to healthcare providers in a market where 86,000 vertebral fragility fractures occur annually, most undiagnosed. Furthermore, the collaboration with Intel to run AI inference locally on hospital hardware could accelerate adoption by addressing concerns about data security and cloud dependency, making AI more practical for real-world clinical settings. As healthcare systems worldwide grapple with rising imaging volumes and workforce shortages, solutions that extract more value from existing scans without additional cost or radiation exposure are increasingly essential. Nanox's dual strategy not only advances its commercial footprint but also strengthens the technological foundation for scalable AI deployment, ultimately benefiting patients and providers alike.